Log in

Start Your Membership Now

Bristol Myers Squibb (BMS) is set to acquire Karuna Therapeutics, a biopharmaceutical company which is focused on treatments for psychiatric and neurological conditions. BMS said the deal has a total equity value of $14 billion. The transaction has been approved by the boards of both companies and is expected to close in the first half of 2024, pending regulatory approvals.  

Karuna’s KarXT (xanomeline-trospium), its lead asset, is an antipsychotic that targets both the M1 and M4 muscarinic receptors, resulting in a differentiated safety and efficacy profile. It has demonstrated improvements in cognition and is not associated with common . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Health Care System

The United States health care system encompasses a mixture of private and public entities that are either non-profit or for-profit. Health care coverage may be financed through federal and state government programs or can be purchased through the health insurance marketplace. In contrast, a smaller proportion of the U.S. population is uninsured. The resulting effects of a decentralized system has led to considerable challenges for provider organizations—including cost pressures, a push towards alternative payment models, and market consolidation. Despite these challenges, there are opportunities for provider organizations in reducing excess costs and utilization, particularly as payers look for innovative approaches that can demonstrate a return-on-investment in terms of cost and consumer outcomes.

Editor’s Picks

Latest Resources
See All
Maryland Expands Advanced Primary Care To Medicare & Medicaid Members
On January 21, 2026, the Maryland Department of Health announced that the state expanded its advanced primary care delivery system to cover approximately 1.2 million residents enrolled in Medicare and Medicaid. The expansion, which took effect January 1, aims to improve preventive care and reduce unnecessary hospital visits by focusing on coordinated care and addressing social determinants of health. The state now operates three advanced primary care programs designed to give care teams more time… Read

To sign-up for monthly Health Care System alerts, you must be signed in to your account.

Government Contract Bidding Opportunities

Government Contract Award Announcements